Atypical response to all-trans retinoic acid in a der(5)t(5;17) acute promyelocytic leukemia

Leukemia

Volumn 13, Issue 6, 1999, Pages 862-868

  Mozziconacci, M J ^a,b   Liberatore, C ^c   Grignani, F ^c   Sainty, D ^a   Pelicci, P G ^c,d   Birg, F ^b   Lafage Pochitaloff, M ^a,b  

^a INSTITUT PAOLI CALMETTES   (France)

^b INSERM   (France)

^c UNIVERSITY OF PERUGIA   (Italy)

^d EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Acute promyelocytic leukemia; All trans retinoic acid; Der(5)t(5; 17); PML nuclear bodies; RARA

Indexed keywords

RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; AGED; ARTICLE; CASE REPORT; CHROMOSOME TRANSLOCATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

EID: 0032969850     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401412     Document Type: Article

References (42)

1. Larson RA, Kondo K, Wardiman JW, Butler AE, Golom HM, Rowley JD. Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia. Am J Med 1984; 76: 827-841.
2. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu HT, Wang ZY. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567-572.
3. Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P, Degos L. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 1990; 76: 1704-1709.
4. Chomienne C, Ballerini P, Balitrand N, Daniel MT, Fenaux P, Castaigne S, Degos L. All-trans retinoic acid in acute promyelocytic leukemia. II. In vitro studies: structure-function relationship. Blood 1990; 76: 1710-1717.
5. Warrell RP Jr, Frankel SR, Miller WH Jr, Sheinberg DA, Itri LM, Hittelman WN, Vyas R, Andreeff R, Tafuri A, Jakubowski A, Gabrilove J, Gordon MS, Dmitrowski E. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). New Engl J Med 1991; 324: 1385-1393.
6. Degos L, Dombret H, Chomienne C, Daniel MT, Micléa JM, Chastaing C, Castaigne S, Fenaux P. All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood 1995; 85: 2643-2653.
7. Grignani F, Pelicci PG. Pathogenetic role of the PML/RARα fusion protein in acute promyelocytic leukemia. Curr Top Microbiol Immunol 1996; 211: 269-278.
8. Tallman M, Andersen J, Schiffer C, Appelbaum F, Feusner J, Ogden A, Shepherd L, Willman C, Bloomfield C, Rowe J, Wiernik P. Alltrans retinoic acid in acute promyelocytic leukemia. New Engl J Med 1997; 337: 1021-1028.
9. Chen Z, Brand NJ, Chen A, Chen SJ, Tong JH, Wang ZY, Waxman S, Zelent A. Fusion between a novel Krüppel-like zinc finger gene and the retinoic acid receptor-a locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. EMBO J 1993; 12: 1161-1167.
10. Licht JD, Chomienne C, Goy A, Chen A, Scott AA, Head DR, Michaux JL, Wu Y, DeBlasio A, Miller WH Jr, Zelent AD, Willman CL, Chen Z, Chen SJ, MacIntyre E, Veil A, Cortes J, Kantarjian H, Waxman S. Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17). Blood 1995; 85: 1083-1094.
11. Corey SJ, Locker J, Oliver DR, Shekter-Levin S, Redner RL, Penchanski I, Gollin SM. A non-classical translocation involving 17q12 (retinoic acid receptor α) in acute promyelocytic leukemia (APML) with atypical features. Leukemia 1994; 8: 1350-1353.
12. Redner RL, Rush EA, Faas S, Rudert WA, Corey SJ. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin retinoic acid receptor fusion. Blood 1996; 87: 882-886.
13. Kamel-Reid S, Hummel JL, Wells RA, Dube ID, Licht JD. Deregulation of NPM and PLZF in a variant t(5;17) case of acute promyelocytic leukemia. Blood 1998; 92 (Suppl. 1): 212a.
14. Wells RA, Hummel JL, de Koven A, Zipursky A, Kirby M, Dube I, Kamel-Reid S. A new variant translocation in acute promyelocytic leukemia: molecular characterization and clinical correlation. Leukemia 1996; 10: 735-740.
15. Wells RA, Catzavelos C, Kamel-Reid S. Fusion of retinoic acid receptor α to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia. Nat Genet 1997; 17: 109-113.
16. Guidez F, Huang W, Tong JH, Dubois C, Balitrand N, Waxman S, Michaux JL, Martial P, Degos L, Chen Z, Chomienne C (1994) Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RARα patient. Leukemia 1994; 8: 312-317.
17. Culligan DJ, Stevenson D, Chee YL, Grimwade D. Acute promyelocytic leukemia with t(11;17)(q23;q12-21) and a good initial response to prolonged ATRA and combination chemotherapy. Br J Haematol 1998; 100: 328-330.
18. Redner RL, Corey SJ, Rush EA. Differentiation of t(5;17) variant acute promyelocytic leukemic blasts by all-trans retinoic acid. Leukemia 1997; 11: 1014-1016.
19. Brunel V, Sainty D, Carbuccia N, Arnoulet C, Costello R, Mozziconacci MJ, Simonetti J, Coignet L, Gabert J, Stoppa AM, Birg F, Lafage-Pochitaloff M. Unbalanced translocation t(5;17) in an atypical acute promyelocytic leukemia. Genes Chromosom Cancer 1995; 14: 307-312.
20. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposals for the classification of the acute leukemias. Br J Haematol 1976; 33: 451-458.
21. Sambrook J, Fritsch E, Maniatis T. Molecular Cloning. A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 1989.
22. Cordell JL, Pulford KAF, Bigerna B, Roncador G, Banham A, Colombo E, Pelicci PG, Mason DY, Falini B. Detection of normal and chimeric nucleophosmin in human cells. Blood 1999; 93: 632-642.
23. Lanotte M, Martin-Thouvenin V, Najman S, Ballerini P, Valensi F, Berger R. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 1991; 77: 1080-1086.
24. Collins SJ, Bodner A, Ting R, Gallo RC. Induction of morphological and functional differentiation of human promyelocytic leukemia cells (HL60) by compunds which induce differentiation of murine leukemia cells. Int J Cancer 1980; 25: 213-218.
25. Mozziconacci MJ, Liberatore C, Brunel V, Grignani F, Arnoulet C, Ferrucci PF, Fernandez F, Sainty D, Pelicci PG, Birg F, Lafage-Pochitaloff M. In vitro response to all-trans retinoic acid of acute promyelocytic leukemias with non reciprocal PML/RARA or RARA/PML fusion genes. Genes Chromosom Cancer 1998; 22: 241-250.
26. Flenghi L, Fagioli M, Tomassoni L, Pileri S, Gambacorta M, Pacini R, Grignani Fr, Casini T, Ferrucci PF, Martelli MF, Pelicci PG, Falini B. Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia. Blood 1995; 85: 1871-1880.
27. Jansen JH, de Ridder MC, Geertsma WMC, Eperlinck CAJ, Smit B, Slater R, van der Reijden BA, de Greef GE, Sonneveld P, Löwenberg B. Complete remission of t(11;17) positive acute promyelocytic leukemia by all-trans retinoic acid and G-CSF. Blood 1998; 92 (Suppl. 1): 402a.
28. Dyck JA, Maul GG, Miller WH Jr, Chen JD, Kakizuka A, Evans RM. A novel macromolecular structure is a target of the promyelocyticretinoic acid receptor oncoprotein. Cell 1994; 76: 333-343.
29. Koken MH, Puvion-Dutilleul F, Guillemin MC, Viron A, Linares-Cruz G, Stuurman N, de Jong L, Szostecki C, Calvo F, Chomienne C, Degos L, Puvion E, de Thé H. The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J 1994; 13: 1073-1083.
30. Weis K, Rambaud S, Lavau C, Jansen J, Carvalho T, Carmo-Fonseca M, Lamond A, Dejean A. Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells. Cell 1994; 76: 345-356.
31. Dyck JA, Warrel RP Jr, Evans RM, Miller WH Jr. Rapid diagnosis of acute promyelocytic leukemia by immunohistochemical localization of PML/RAR alpha protein. Blood 1995; 86: 862-867.
32. O'Connor SJ, Forsyth PD, Dalal S, Evans PA, Short MA, Shiach C, Jack AS, Morgan G. The rapid diagnosis of acute promyelocytic leukemia using PML (5E10) monoclonal antibody. Br J Haematol 1997; 99: 597-604.
33. Falini B, Flenghi L, Fagioli M, Lo Coco F, Cordone I, Diverio D, Pasqualucci I, Biondi A, Riganelli D, Orleth A, Liso A, Martelli MF, Pelicci PG, Pileri S. Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML). Blood 1997; 90: 4046-4053.
34. Perez A, Kastner P, Sethi S, Lutz Y, Reibel C, Chambon P. PML-RARA homodimers: distinct DNA binding properties and heteromeric interactions with RXR. EMBO J 1993; 12: 3171-3182.
35. Grimwade D, Gorman P, Duprez E, Howe K, Langabeer S, Oliver F, Walker H, Culligan D, Waters J, Pomfret M, Goldstone A, Burnett A, Freemont P, Sheer D, Solomon E. Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia. Blood 1997; 90: 4876-4885.
36. Lafage-Pochitaloff M, Alcalay M, Brunel V, Longo L, Sainty D, Simonetti J, Birg F, Pelicci PG. Acute promyelocytic leukemia cases with nonreciprocal PML/RARa or RARa/PML fusion genes. Blood 1995; 85: 1169-1174.
37. Grignani F, De Mattels S, Nervi C, Tomassoni L, Gelmnetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Zamir I, Seiser C, Grignani F, Lazar MA, Minucci S, Pelicci PG. Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia. Nature 1998; 391: 815-818.
38. Guidez F, Ivins S, Zhu J, Söderström M, Waxman S, Zelent A. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARa underlie molecular pathogenesis and treatment of acute promyelocytic leukemia. Blood 1998; 91: 2634-2642.
39. He LZ, Guidez F, Tribioli C, Peruzzi D, Ruthardt M, Zelent A, Pandolfi PP. Distinct interactions of PML/RARAα and PLZF/RARα with co-repressors determine differential responses to RA in APL. Nat Genet 1998; 18: 126-135.
40. Lin RJ, Nagy L, Inoue S, Shao W, Miller WH Jr, Evans RM. Role of the histone deacetylase complex in acute promyelocytic leukemia. Nature 1998; 391: 811-814.
41. Collins SJ. Acute promyelocytic leukemia: relieving repression induces remission. Blood 1998; 91: 2631-2633.
42. Look AT. Arsenic and apoptosis in the treatment of acute promyelocytic leukemia. J Natl Cancer Inst 1998; 90: 86-88.